| New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) EA Eisenhauer, P Therasse, J Bogaerts, LH Schwartz, D Sargent, R Ford, ... European journal of cancer 45 (2), 228-247, 2009 | 28219 | 2009 |
| iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics L Seymour, J Bogaerts, A Perrone, R Ford, LH Schwartz, S Mandrekar, ... The Lancet Oncology 18 (3), e143-e152, 2017 | 1975 | 2017 |
| RECIST 1.1—Update and clarification: From the RECIST committee LH Schwartz, S Litière, E De Vries, R Ford, S Gwyther, S Mandrekar, ... European journal of cancer 62, 132-137, 2016 | 1513 | 2016 |
| Imaging biomarker roadmap for cancer studies JPB O'connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ... Nature reviews Clinical oncology 14 (3), 169-186, 2017 | 1045 | 2017 |
| Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials LK Shankar, JM Hoffman, S Bacharach, MM Graham, J Karp, ... Journal of Nuclear Medicine 47 (6), 1059-1066, 2006 | 811 | 2006 |
| Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development GJ Kelloff, JM Hoffman, B Johnson, HI Scher, BA Siegel, EY Cheng, ... Clinical Cancer Research 11 (8), 2785-2808, 2005 | 809 | 2005 |
| Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials BM Ellingson, M Bendszus, J Boxerman, D Barboriak, BJ Erickson, ... Neuro-oncology 17 (9), 1188-1198, 2015 | 649 | 2015 |
| Evaluation of lymph nodes with RECIST 1.1 LH Schwartz, J Bogaerts, R Ford, L Shankar, P Therasse, S Gwyther, ... European journal of cancer 45 (2), 261-267, 2009 | 323 | 2009 |
| Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents JE Dancey, KK Dobbin, S Groshen, JM Jessup, AH Hruszkewycz, ... Clinical cancer research 16 (6), 1745-1755, 2010 | 295 | 2010 |
| RECIST 1.1–Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group LH Schwartz, L Seymour, S Litière, R Ford, S Gwyther, S Mandrekar, ... European journal of cancer 62, 138-145, 2016 | 284 | 2016 |
| Repeatability of 18F-FDG uptake measurements in tumors: a metaanalysis AJ De Langen, A Vincent, LM Velasquez, H Van Tinteren, R Boellaard, ... Journal of Nuclear Medicine 53 (5), 701-708, 2012 | 183 | 2012 |
| Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer SJ Mandel, LK Shankar, F Benard, A Yamamoto, A Alavi Clinical nuclear medicine 26 (1), 6-9, 2001 | 166 | 2001 |
| Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases TJ Kaufmann, M Smits, J Boxerman, R Huang, DP Barboriak, M Weller, ... Neuro-oncology 22 (6), 757-772, 2020 | 164 | 2020 |
| Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas JL Boxerman, CC Quarles, LS Hu, BJ Erickson, ER Gerstner, M Smits, ... Neuro-oncology 22 (9), 1262-1275, 2020 | 154 | 2020 |
| Validation of novel imaging methodologies for use as cancer clinical trial end-points DJ Sargent, L Rubinstein, L Schwartz, JE Dancey, C Gatsonis, LE Dodd, ... European journal of cancer 45 (2), 290-299, 2009 | 145 | 2009 |
| Recommendations for the assessment of progression in randomised cancer treatment trials JE Dancey, LE Dodd, R Ford, R Kaplan, M Mooney, L Rubinstein, ... European journal of cancer 45 (2), 281-289, 2009 | 131 | 2009 |
| Lessons learned from independent central review R Ford, L Schwartz, J Dancey, LE Dodd, EA Eisenhauer, S Gwyther, ... European journal of cancer 45 (2), 268-274, 2009 | 130 | 2009 |
| A Phase 2 Study of 16α-[18F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC) LM Peterson, BF Kurland, EK Schubert, JM Link, VK Gadi, JM Specht, ... Molecular imaging and biology 16, 431-440, 2014 | 104 | 2014 |
| The quantitative imaging network: NCI's historical perspective and planned goals LP Clarke, RJ Nordstrom, H Zhang, P Tandon, Y Zhang, G Redmond, ... Translational oncology 7 (1), 1-4, 2014 | 96 | 2014 |
| Regulatory aspects of optical methods and exogenous targets for cancer detection WS Tummers, JM Warram, KE Tipirneni, J Fengler, P Jacobs, L Shankar, ... Cancer research 77 (9), 2197-2206, 2017 | 83 | 2017 |
